Clinical trials: Chronic Lymphoproliferative Diseases (CLPD)
- Condition Chronic Lymphoproliferative Diseases (CLPD)
- Funder type Industry (pharma, biotech, devices)
Chronic Lymphoproliferative Diseases (CLPD)
BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.
Multi-site, prospective performance study to determine equivalency between the investigational CLPD Full Panel on the FACSLyric system versus the final clinical diagnosis.
- Trial name
- NCT05557422
- Testing
- BD OneFlow LST, and B-CLPD T1 to T4 Assays
- Where
- 6 sites in United States, Netherlands and 3 more
- Volunteers
- 322 people
- Sponsor
- Becton, Dickinson and Company
Chronic Lymphoproliferative Diseases (CLPD)
Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer
Multi-site, prospective performance study to determine equivalency between the investigational CLPD Limited Panel on the FACSLyric system versus the final clinical diagnosis.
- Trial name
- NCT05032313
- Testing
- IUO CLPD Limited Panel
- Where
- 6 sites in United States, Portugal and 3 more
- Volunteers
- 371 people
- Sponsor
- Becton, Dickinson and Company